These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2348847)

  • 21. Cross immunity among types of Borrelia burgdorferi.
    Wienecke R; Neubert U; Volkenandt M
    Lancet; 1993 Aug; 342(8868):435. PubMed ID: 8101930
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunodiagnosis of Lyme borreliosis.
    Dattwyler RJ; Luft BJ
    Rheum Dis Clin North Am; 1989 Nov; 15(4):727-34. PubMed ID: 2685927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serologic testing only part of Lyme diagnosis.
    Yost JH; Spencer-Green G
    J Am Osteopath Assoc; 1992 Oct; 92(10):1218-20. PubMed ID: 1459869
    [No Abstract]   [Full Text] [Related]  

  • 24. [Determination of anti-Borrelia burgdorferi antibodies in symptomatic and control patients].
    Scapini JP; Hadad MA; Battagliotti C; Teglia O
    Rev Argent Microbiol; 1999; 31 Suppl 1():62-4. PubMed ID: 10509418
    [No Abstract]   [Full Text] [Related]  

  • 25. Apoptosis of Fashigh CD4+ synovial T cells by borrelia-reactive Fas-ligand(high) gamma delta T cells in Lyme arthritis.
    Vincent MS; Roessner K; Lynch D; Wilson D; Cooper SM; Tschopp J; Sigal LH; Budd RC
    J Exp Med; 1996 Dec; 184(6):2109-17. PubMed ID: 8976167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of Lyme disease.
    Malawista SE
    Rheumatol Int; 1989; 9(3-5):233-5. PubMed ID: 2692132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis.
    Dressler F; Ackermann R; Steere AC
    J Infect Dis; 1994 Feb; 169(2):313-8. PubMed ID: 8106763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of Borrelia burgdorferi from a Lyme seronegative patient in northern Italy: expression of OspB immunodominant proteins on the isolated strain.
    Cinco M; Trevisan G; Agolzer A
    Microbiologica; 1992 Apr; 15(2):95-8. PubMed ID: 1602993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.
    Lengl-Janssen B; Strauss AF; Steere AC; Kamradt T
    J Exp Med; 1994 Dec; 180(6):2069-78. PubMed ID: 7964484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lyme disease serology: problems and opportunities.
    Wormser GP; Aguero-Rosenfeld ME; Nadelman RB
    JAMA; 1999 Jul; 282(1):79-80. PubMed ID: 10404917
    [No Abstract]   [Full Text] [Related]  

  • 31. Analysis of T lymphocytes cloned from the synovial fluid and blood of a patient with Lyme arthritis.
    Yssel H; Nakamoto T; Schneider P; Freitas V; Collins C; Webb D; Mensi N; Soderberg C; Peltz G
    Int Immunol; 1990; 2(11):1081-9. PubMed ID: 2083228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcoidosis and ELISA for Borrelia burgdorferi.
    Morris JT; Longfield RN
    South Med J; 1994 Jun; 87(6):590-1. PubMed ID: 8202765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antibody indicating Lyme disease in farmers in Wigtownshire.
    Baird AG; Gillies JC; Bone FJ; Dale BA; Miscampbell NT
    BMJ; 1989 Sep; 299(6703):836-7. PubMed ID: 2510849
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of antibody indicating Lyme disease in farmers in Wigtownshire.
    Baxter MA; Wright AD
    BMJ; 1989 Nov; 299(6709):1221. PubMed ID: 2513072
    [No Abstract]   [Full Text] [Related]  

  • 35. Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells.
    Fikrig E; Barthold SW; Chen M; Chang CH; Flavell RA
    J Immunol; 1997 Dec; 159(11):5682-6. PubMed ID: 9548512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.
    Callister SM; Schell RF; Case KL; Lovrich SD; Day SP
    J Infect Dis; 1993 Jan; 167(1):158-64. PubMed ID: 8418162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serological screening for Lyme disease in Israel].
    Kletter Y; Berger SA
    Harefuah; 1993 Nov; 125(9):261-3, 328. PubMed ID: 8253415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lyme borreliosis in Spain: a serological survey.
    Guerrero A; Escudero R; Martí-Belda P; Quereda C; Miramón J
    Clin Infect Dis; 1994 Mar; 18(3):493-4. PubMed ID: 8011855
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute myelo-meningo-radiculitis caused by the spirochaete Borrelia burgdorferi].
    Jensen EL; Christensen BI
    Ugeskr Laeger; 1992 Nov; 154(49):3512-3. PubMed ID: 1462471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.